Traders sold shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) on strength during trading on Monday. $78.76 million flowed into the stock on the tick-up and $136.89 million flowed out of the stock on the tick-down, for a money net flow of $58.13 million out of the stock. Of all companies tracked, Walgreens Boots Alliance had the 0th highest net out-flow for the day. Walgreens Boots Alliance traded up $0.59 for the day and closed at $76.82
A number of analysts have recently issued reports on the company. ValuEngine upgraded Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a research report on Friday, September 21st. TheStreet upgraded Walgreens Boots Alliance from a “c+” rating to a “b” rating in a research report on Wednesday, September 12th. BidaskClub upgraded Walgreens Boots Alliance from a “buy” rating to a “strong-buy” rating in a research report on Tuesday, August 21st. Cowen downgraded Walgreens Boots Alliance from an “outperform” rating to a “market perform” rating and set a $104.00 price target for the company. in a research report on Monday, July 23rd. Finally, Pivotal Research lifted their price target on Walgreens Boots Alliance from $60.00 to $72.00 and gave the company a “hold” rating in a research report on Monday, October 15th. One investment analyst has rated the stock with a sell rating, eleven have assigned a hold rating, seven have assigned a buy rating and two have issued a strong buy rating to the company’s stock. The stock currently has an average rating of “Hold” and a consensus target price of $78.22.
The stock has a market capitalization of $72.35 billion, a price-to-earnings ratio of 12.76, a P/E/G ratio of 1.19 and a beta of 1.04. The company has a debt-to-equity ratio of 0.47, a current ratio of 0.82 and a quick ratio of 0.38.
The company also recently announced a quarterly dividend, which will be paid on Wednesday, December 12th. Investors of record on Monday, November 12th will be given a $0.44 dividend. The ex-dividend date of this dividend is Thursday, November 8th. This represents a $1.76 dividend on an annualized basis and a yield of 2.29%. Walgreens Boots Alliance’s payout ratio is 29.24%.
In related news, Director William C. Foote sold 2,736 shares of the business’s stock in a transaction that occurred on Thursday, August 2nd. The stock was sold at an average price of $65.99, for a total value of $180,548.64. Following the completion of the sale, the director now owns 10,943 shares in the company, valued at approximately $722,128.57. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Insiders own 14.80% of the company’s stock.
Institutional investors have recently made changes to their positions in the business. BlueMountain Capital Management LLC purchased a new position in shares of Walgreens Boots Alliance during the second quarter valued at approximately $103,000. CSat Investment Advisory L.P. purchased a new position in shares of Walgreens Boots Alliance during the second quarter valued at approximately $104,000. Squar Milner Financial Services LLC purchased a new position in shares of Walgreens Boots Alliance during the second quarter valued at approximately $106,000. Asset Dedication LLC increased its stake in shares of Walgreens Boots Alliance by 204.6% during the third quarter. Asset Dedication LLC now owns 1,578 shares of the pharmacy operator’s stock valued at $115,000 after buying an additional 1,060 shares during the period. Finally, Kaizen Advisory LLC increased its stake in shares of Walgreens Boots Alliance by 128.6% during the second quarter. Kaizen Advisory LLC now owns 1,925 shares of the pharmacy operator’s stock valued at $116,000 after buying an additional 1,083 shares during the period. 64.81% of the stock is currently owned by institutional investors and hedge funds.
Walgreens Boots Alliance Company Profile (NASDAQ:WBA)
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of general merchandise, including non-prescription drugs, beauty products, photo finishing, seasonal merchandise, greeting cards, and convenience foods through its retail drugstores and convenient care clinics.
Further Reading: Yield Curve
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.